About 500 reports

  • Global Kaposi sarcoma HAART therapy market 2016-2021 ($ millions)
  • MARKET DRIVERS

About Kaposi Sarcoma Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, epidemic, and iatrogenic forms. Epidemic or acquired immune deficiency syndrome (AIDS)-associated form of treatment is...

  • Cancer
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • 5.1 DRIVERS

Some of the programs are specific for conditions, like HIV/ AIDS or cancer.

  • Cancer
  • United States
  • Amgen Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.

However, the region holds strong potential due to hundreds of clinical trials being performed in the region, more specifically in the US, for the treatment of cancer, HIV/ AIDS, and other diseases.

  • Cancer
  • World
  • Forecast
  • Market Size
  • Celgene Corporation
  • Cervical Cancer Diagnostics Market: Product Outlook

AIDS Acquired immune deficiency syndrome ##.

  • Cancer
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.

© IGATE RESEARCH PAGE ## OF ## Global Cervical Cancer Screening Market - Overview Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world.

  • Cancer
  • Cervical Cancer
  • Medical Device
  • Sexually Transmitted Disease
  • Forecast
  • 11.3 Factors that Impede Market Growth

Bowel wall perforation or tears Bleeding Infection and other blood-borne diseases such as hepatitis, HIV, and AIDS can be transmitted from one individual to the other if sterilization is not done properly.

  • Cancer
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation

PRIOR TO JOINING GLOBALDATA, NATASHA WORKED AS AN EPIDEMIOLOGIST FOR THREE YEARS IN THE HIV/ AIDS SURVEILLANCE PROGRAM AT THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (MDPH).

  • Cancer
  • Hormone
  • Prostate Cancer
  • Therapy
  • PROVENGE group

BMS DRUGS PORTFOLIO INCLUDE MEDICINES THAT TREAT CANCER, CARDIOVASCULAR DISEASE, HEPATITIS B AND HEPATITIS C, HIV/ AIDS, RHEUMATOID ARTHRITIS AND DERMATOLOGY.

  • Cancer
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

HIV/ AIDS, Tuberculosis (TB) remains a global public health problem and is one of the three leading causes of deaths worldwide due to infectious diseases.

  • Cancer
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.
  • TREATMENT USAGE RATES
  • TREATED POPULATION

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer is anticipated to become increasingly prevalent due to aging populations and rising levels of obesity in the developed world. Cancer vaccines...

  • Cancer
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

Cervical Cancer Mortality Population (2001 - 2011) ##.

  • Cancer
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Medical Device
  • Forecast

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.

However, it is also one of the most preventable types of cancer.

  • Cancer
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • North America
  • Forecast

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Disease control efforts for viral Hepatitis, Tuberculosis and HIV/ AIDS remain important issues for China.

  • Cancer
  • In Vitro Diagnostic Reagent
  • China
  • East Asia
  • OriGene Technologies, Inc.
  • 3.2 RISK FACTORS AND COMORBIDITIES
  • Risk Factors and Comorbidities for NHL

EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024 Summary Non-Hodgkin’s Lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the body’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fight...

  • Cancer
  • Japan
  • United States
  • World
  • Forecast

These points have been further sub ##.

  • Cancer
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Southeast Asia
  • Forecast
  • MARKET OUTLINE

However, Africa is the major market for infectious diseases because of increased prevalence of UTIs and HIV.

  • Cancer
  • Sexually Transmitted Disease
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Bristol-Myers Squibb China Inc Ltd
  • Sanofi-Synthelabo Inc.
  • Schering-Plough Corporation

THESE STUDIES INTO THE SAFETY AND EFFICACY OF INVESTIGATIONAL PRODUCTS FIGURE ##-##: GSK VACCINE PRODUCT PIPELINE IMPACT AROUND THE WORLD, INCLUDING MALARIA, HIV, TB AND EBOLA.

  • Cancer
  • World
  • GlaxoSmithKline plc
  • Meningococcal group
  • Pfizer Inc.

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Biostar Pharmaceuticals, Inc.
  • Novartis AG
  • Sanofi-Synthelabo Inc.

Roche is one of the major players in the market.

  • Cancer
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Australia
  • United States
  • World
  • Forecast

CURRENT IMMUNE MEDIATED DISEASE FOCUS MORE ON HIV/ AIDS, TUBERCULOSIS, PNEUMONIA, ENTERIC DISEASES AND MALARIA.

  • Cancer
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • China
  • Japan
  • United States
  • Forecast
  • BRISTOL-MYERS SQUIBB COMPANY

This report, the World Market for Cancer Therapeutics presents a detailed picture of the market for cancer drugs, with a focus on novel therapies. The market analysis in this report includes analysis of products avaiable for each cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Colon Cancer and Other types)...

  • Cancer
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

In addition to HIV/ AIDS, Tuberculosis (TB) remains a global public health problem and is one of the three leading causes of deaths worldwide due to infectious diseases.

  • Cancer
  • North America
  • United States
  • Cepheid
  • Myriad Genetics, Inc.

It concentrates its R& D efforts in the area of diseases with significant unmet medical needs: HIV/ AIDS, oncology, hepatitis, immunologic disorders, and cardiovascular and fibrotic disease.

  • Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.